RAPPORT THERAPEUTICS INC (RAPP) Stock Analyst Earnings Estimates
NASDAQ:RAPP - Nasdaq - US75383L1026 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | ||||
| EBITDA YoY % growth | -10.352M | -35.89M -246.70% | -82.16M -128.92% | N/A -69.30% | N/A -38.60% | N/A -39.00% | |
| EBIT YoY % growth | -10.367M | -36M -247.26% | -83M -130.56% | N/A -67.57% | N/A -43.94% | N/A -28.70% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 11.22% | N/A -31.25% | N/A -13.12% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.85 50.10% | -0.87 -73.06% | -0.93 -63.14% | -1.09 -60.00% | -0.97 -14.23% | -1.24 -43.81% | -1.28 -37.11% |
| Revenue Q2Q % growth | |||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -32.401M -54.29% | -37.481M -70.37% | -41.635M -73.48% | -48.205M -78.54% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.68 | -0.78 | 0.10 | 12.28% |
| Q4 2024 Q2Q % growth | -0.57 | -0.64 | 0.07 | 10.59% |
| Q3 2024 Q2Q % growth | -0.50 | -0.59 | 0.09 | 14.90% |
| Q2 2024 Q2Q % growth | -1.70 | -0.69 | -1.01 | -146.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 3.85% | 0% | 5.51% |
| Revenue | N/A | N/A | N/A | N/A |